CASI

Analysts Estimate CASI Pharmaceuticals, Inc. (CASI) to Report a Decline in Earnings: What to Look Out for

CASI Pharmaceuticals Announces Dosing Of First Patient Of CID-103 In Phase 1 Clinical Trial For Relapsed Or Refractory Multiple Myeloma

CASI Pharmaceuticals, Inc. To Participate In Jefferies Virtual Healthcare Conference

CASI Pharmaceuticals, Inc. (CASI) CEO Dr. Wei-Wu He on Q1 2021 Results - Earnings Call Transcript

CASI Pharmaceuticals To Report First Quarter 2021 Financial Results And Host Conference Call May 13, 2021

CASI Stock: $3.80 Target By Mizuho

CASI Stock Price Increased Over 10% Pre-Market: Why It Happened